Golnaz Kamalinia

715 total citations
17 papers, 573 citations indexed

About

Golnaz Kamalinia is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Golnaz Kamalinia has authored 17 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Golnaz Kamalinia's work include Nanoparticle-Based Drug Delivery (5 papers), Curcumin's Biomedical Applications (2 papers) and Infant Nutrition and Health (2 papers). Golnaz Kamalinia is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Curcumin's Biomedical Applications (2 papers) and Infant Nutrition and Health (2 papers). Golnaz Kamalinia collaborates with scholars based in Iran, United States and Switzerland. Golnaz Kamalinia's co-authors include Rassoul Dinarvand, Fatemeh Atyabi, Mohsen Amini, Navid Goodarzi, Reyhaneh Varshochian, Seyed Nasser Ostad, Behrad Darvishi, Mirhamed Hajimiri, Mohammad Sharifzadeh and Fatemeh Shaerzadeh and has published in prestigious journals such as Chemical Society Reviews, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Golnaz Kamalinia

17 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Golnaz Kamalinia Iran 11 232 213 122 88 49 17 573
Mahmoud Gharbavi Iran 14 193 0.8× 208 1.0× 165 1.4× 164 1.9× 40 0.8× 25 605
Xiaojun Shi China 16 170 0.7× 297 1.4× 118 1.0× 115 1.3× 108 2.2× 40 947
Gitu Pandey India 15 194 0.8× 173 0.8× 160 1.3× 130 1.5× 62 1.3× 19 566
Mahalingam Rajamanickam Vijayakumar India 10 320 1.4× 257 1.2× 150 1.2× 139 1.6× 50 1.0× 13 583
Navid Goodarzi Iran 12 222 1.0× 171 0.8× 133 1.1× 65 0.7× 62 1.3× 25 456
Sara Nikoofal‐Sahlabadi Iran 12 147 0.6× 177 0.8× 125 1.0× 72 0.8× 60 1.2× 16 475
Usamah Sayed Jordan 3 284 1.2× 356 1.7× 198 1.6× 174 2.0× 44 0.9× 4 818
Somayeh Handali Iran 15 372 1.6× 275 1.3× 226 1.9× 146 1.7× 69 1.4× 28 735
Zhen-Hai Zhang China 10 200 0.9× 351 1.6× 130 1.1× 93 1.1× 39 0.8× 12 585
Qiujun Qiu China 16 158 0.7× 259 1.2× 220 1.8× 65 0.7× 100 2.0× 19 727

Countries citing papers authored by Golnaz Kamalinia

Since Specialization
Citations

This map shows the geographic impact of Golnaz Kamalinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Golnaz Kamalinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Golnaz Kamalinia more than expected).

Fields of papers citing papers by Golnaz Kamalinia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Golnaz Kamalinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Golnaz Kamalinia. The network helps show where Golnaz Kamalinia may publish in the future.

Co-authorship network of co-authors of Golnaz Kamalinia

This figure shows the co-authorship network connecting the top 25 collaborators of Golnaz Kamalinia. A scholar is included among the top collaborators of Golnaz Kamalinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Golnaz Kamalinia. Golnaz Kamalinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kamalinia, Golnaz, Brian J. Grindel, Terry T. Takahashi, Steven W. Millward, & Richard W. Roberts. (2021). Directing evolution of novel ligands by mRNA display. Chemical Society Reviews. 50(16). 9055–9103. 45 indexed citations
2.
Kamalinia, Golnaz, Brian J. Engel, Brian J. Grindel, et al.. (2020). mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1). ACS Chemical Biology. 15(6). 1630–1641. 11 indexed citations
3.
Saxena, Roopali, Chunhua Yang, Rao Mukkavilli, et al.. (2017). Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment. Clinical Cancer Research. 23(14). 3781–3793. 14 indexed citations
4.
Kamalinia, Golnaz, et al.. (2017). Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells. Artificial Cells Nanomedicine and Biotechnology. 46(3). 626–636. 39 indexed citations
5.
Darvishi, Behrad, Golnaz Kamalinia, Nasrin Samadi, et al.. (2015). Preparation and Antibacterial Activity Evaluation of 18-β-glycyrrhetinic Acid Loaded PLGA Nanoparticles.. PubMed. 14(2). 373–83. 31 indexed citations
6.
Kamalinia, Golnaz, Fariba Khodagholi, Fatemeh Shaerzadeh, et al.. (2015). Cationic Albumin‐Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration. Chemical Biology & Drug Design. 86(5). 1203–1214. 33 indexed citations
7.
Kamalinia, Golnaz, Mohsen Amini, Seyed Nasser Ostad, et al.. (2014). Targeted poly (l-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. International Journal of Pharmaceutics. 467(1-2). 123–138. 40 indexed citations
8.
Hajimiri, Mirhamed, et al.. (2014). Growth factor conjugation: Strategies and applications. Journal of Biomedical Materials Research Part A. 103(2). 819–838. 50 indexed citations
9.
Darvishi, Behrad, Golnaz Kamalinia, Mohsen Amini, et al.. (2013). Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU Journal of Pharmaceutical Sciences. 21(1). 58–58. 104 indexed citations
10.
Dinarvand, Rassoul, Reyhaneh Varshochian, Golnaz Kamalinia, Navid Goodarzi, & Fatemeh Atyabi. (2013). Recent approaches to overcoming multiple drug resistance in breast cancer using modified liposomes. Clinical Lipidology. 8(4). 391–394. 2 indexed citations
11.
Kamalinia, Golnaz, Fariba Khodagholi, Fatemeh Atyabi, et al.. (2013). Enhanced Brain Delivery of Deferasirox–Lactoferrin Conjugates for Iron Chelation Therapy in Neurodegenerative Disorders: In Vitro and in Vivo Studies. Molecular Pharmaceutics. 10(12). 4418–4431. 61 indexed citations
12.
Goodarzi, Navid, Reyhaneh Varshochian, Golnaz Kamalinia, Fatemeh Atyabi, & Rassoul Dinarvand. (2012). A review of polysaccharide cytotoxic drug conjugates for cancer therapy. Carbohydrate Polymers. 92(2). 1280–1293. 115 indexed citations
13.
Kamalinia, Golnaz, Serge Brand, Padideh Ghaeli, et al.. (2012). Serum Levels of Sodium Valproate in Patients Suffering from Bipolar Disorders: Comparing Acute and Maintenance Phases of Mania. Pharmacopsychiatry. 46(3). 83–87. 2 indexed citations
14.
Gholami, Kheirollah, Golnaz Kamalinia, Mohammad Mahdi Ahmadian-Attari, & Jamshid Salamzadeh. (2012). Three years evaluation of drug shortages from educational pharmacies in tehran.. PubMed. 11(2). 565–72. 5 indexed citations
15.
Jamalifar, Hossein, et al.. (2009). The Ethnopharmacological Study on Antibacterial Activity of some Selected Plants Used in Iranian Traditional Medicine. SHILAP Revista de lepidopterología. 10 indexed citations
16.
Kamalinia, Golnaz, Mohammad Reza Rouini, Padideh Ghaeli, & Mohsen Amini. (2009). N-(1-Naphthyl)ethylenediamine, a New UV Labeling Reagent Used for LC Determination of Valproic Acid in Human Plasma. Chromatographia. 70(3-4). 569–573. 3 indexed citations
17.
Hajiaghaee, Reza, et al.. (2008). Antifungal and Antibacterial Activities of Pentanema divaricatum and Its Active Constituent. Zeitschrift für Naturforschung C. 63(9-10). 649–652. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahmoud Gharbavi Breakdown of academic impact, for papers by Xiaojun Shi Breakdown of academic impact, for papers by Gitu Pandey Breakdown of academic impact, for papers by Mahalingam Rajamanickam Vijayakumar Breakdown of academic impact, for papers by Navid Goodarzi Breakdown of academic impact, for papers by Sara Nikoofal‐Sahlabadi Breakdown of academic impact, for papers by Usamah Sayed Breakdown of academic impact, for papers by Somayeh Handali Breakdown of academic impact, for papers by Zhen-Hai Zhang Breakdown of academic impact, for papers by Qiujun Qiu
Rankless by CCL
2026